ArticleInternational journal of cancer2026

Optimal Neoadjuvant Approach for Resectable Esophageal Cancer in the Era of Immunotherapy.

Guo Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.